TITLE

Bleeding hepatic adenoma: expectant treatment to limit the extent of liver resection

AUTHOR(S)
Heeringa, Brian; Sardi, Armando; Heeringa, B; Sardi, A
PUB. DATE
October 2001
SOURCE
American Surgeon;Oct2001, Vol. 67 Issue 10, p927
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Hepatic adenomas (HAs) are benign but can present as an acute surgical emergency. The relationship between HA and oral contraceptives (OCs) has been well documented and there have been several reports of tumor regression after the withdrawal of hormonal agents. However, not all HAs regress in this manner; have been reported to remain stable, increase in size, hemorrhage, or rarely, undergo malignant transformation. Given the unpredictable nature of these lesions they are generally treated surgically. In July 1995 a patient with a 6-year history of OC use was admitted with a history of sudden-onset right upper quadrant abdominal pain of 2 days' duration. The clinical picture and imaging studies led to the diagnosis of a bleeding hepatic adenoma without rupture. She was treated expectantly for a period of 14 months before surgery. This allowed the tumor to significantly decrease in size and thus limit the extent of resection. If the patient presented in this case had undergone surgery at the time of initial diagnosis a right hepatic lobectomy as opposed to a wedge resection would have been required. Treating this patient expectantly significantly decreased the potential morbidity associated with a larger resection.
ACCESSION #
5331129

 

Related Articles

  • SELECTED ABSTRACT FOR GASTROENTEROLOGISTS. Mellin, Harold; Schwartz, Alan S. // American Journal of Gastroenterology;Nov1975, Vol. 64 Issue 5, p416 

    Presents an abstract of the study "Focal Nodular Hyperplasia of the Liver and Intrahepatic Hemorrhage In Young Women on Oral Contraceptives," by J. Q. Stauffer, M. W. Lapinski, D. J. Honold, et al. Cases of patients involved in the study; Modes of clinical presentation of the patients;...

  • Scintigraphic Triad in Focal Nodular Hyperplasia. Tanasescu, D.; Brachman, M.; Rigby, J.; Yadegar, J.; Ramanna, L.; Waxman, A. // American Journal of Gastroenterology;Jan1984, Vol. 79 Issue 1, p61 

    Presents cases of focal nodular hyperplasia (FNH). Histological types of lesions of the liver; Scintigraphic findings in tumors of the liver; Possible relationship of FNH to the ingestion of oral contraceptives.

  • Association of adenoma and focal nodular hyperplasia: experience of a single French academic center. Laurent, Christophe; Trillaud, Hervé; Lepreux, Sébastien; Balabaud, Charles; Bioulac-Sage, Paulette // Comparative Hepatology;2003, Vol. 2, p6 

    Background: We report our experience of the simultaneous occurrence of adenoma and focal nodular hyperplasia (FNH). Liver cell adenoma together with FNH was found in five out of 30 cases of "multiple benign hepatocytic nodules" collected in our files of the Department of Pathology of the...

  • Dental problems: part one. Watkins, Jean // Update;5/6/2004, Vol. 68 Issue 8, p429 

    The article presents a pictorial guide to diagnosis and management of common dental problems. Physiological gum pigmentation often affects the gums and/or the buccal mucosa, and occurs frequently in patients with racial skin pigmentation. Pigmentation can occur in conditions such as Addison's...

  • Management of hirsutism. Koulouri, Olympia; Conway, Gerard S. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;4/4/2009, Vol. 338 Issue 7698, p823 

    The article discusses a review of treatment methods for hirsutism. Hirsutism is a condition in women that results in excessive hair growth and can affect the psychological well-being of patients. Causes for hirsutism can include polycystic ovary syndrome, congenital adrenal hyperplasia and...

  • How medications can affect your oral health.  // Journal of the American Dental Association (JADA);Jun2005, Vol. 136 Issue 6, p831 

    Focuses on the side effects of some common medication on oral health. Bleeding problems caused by aspirins and anticoagulants during oral surgery or treatment with periodontal diseases; Link of immunosuppressive agents, oral contraceptives, and some chemotherapeutic agents to the development of...

  • Uterotrophic assay, Hershberger assay, and subacute oral toxicity study of 4,4´-[1-[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl]ethylidene]bis[phenol] based on the OECD draft protocols. Yamasaki, Kanji; Miyata, Katumi; Muroi, Takako; Ehara, Hatsune; Higashihara, Nobuhiko; Houshuyama, Satsuki; Oshima, Hiroshi; Minobe, Yasushi // Archives of Toxicology;Nov2007, Vol. 81 Issue 11, p749 

    We performed an uterotrophic assay, the Hershberger assay, and a 28-day repeated-dose toxicity study (enhanced OECD test guideline No. 407) of 4,4´-[1-[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl]ethylidene]bis[phenol] based on the OECD draft protocols. In the uterotrophic assay, female SD...

  • Oral contraceptives: Warning on certain brands.  // HealthFacts;Dec95, Vol. 20 Issue 199, p4 

    Warns on the negative side effect of third generation oral contraceptives (OCs). Increased risk of non-fatal venous thromboembolism; Two brands of OCs prescribed in the United States; Findings of the World Health Organization's studies on third generation OCs.

  • Contraception: In a pinch, women can still take the pill the next morning.  // Modern Medicine;Jul95, Vol. 63 Issue 7, p30 

    Reports that women can be protected by taking oral contraceptives for several days after having unprotected sex based on surveys conducted by Kaiser Permanente group. Failure rate; Ways of practicing emergency contraception.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics